An estimated 30–40% of cancers can be prevented through changes in modifiable lifestyle
and environmental risk factors known to be associated with cancer incidence. Despite this …

Minority US populations are underrepresented in cancer clinical trials. This review appraises
the impact of the disparity in clinical trial participation by minority patients in the current era …

Many factors contribute to the poor survival of malignant brain tumor patients, some of which
are not easily remedied. However, one contributor to the lack of progress that may be …

Introduction Engaging communities in research planning and implementation can enhance
recruitment and retention (R&R) of racial and ethnic groups historically excluded and …

Abstract Background: In 1971, the National Cancer Act created a process to recognize the
leadership, facilities, and research efforts at cancer centers throughout the United States …

Importance Despite federal initiatives encouraging the enrollment of individuals from racial
and ethnic minority groups in US clinical trials, no studies to date have specifically examined …

PURPOSE Patients with cancer from racial and ethnic minorities, referred to as culturally
and linguistically diverse (CALD) in Australia, are significantly under-represented in cancer …

Radiation therapy (RT) plays an important role in the management of patients with central
nervous system (CNS) tumors. RT is delivered through external beam RT (x-rays, gamma …

Objective This study aimed to identify communication strategies that virtual humans (VHs)
discussing clinical trials can use to foster positive relationships with older women to better …

Background Enrollment in therapeutic cancer trials remains low, and is especially
challenging for patients with low health literacy. The authors tested an interactive technology …